Tonix Pharmaceuticals Announces Selection Of Two Contract Manufacturing Organizations For The Launch And Commercial Manufacture Of Tonmya For Management Of Fibromyalgia; NDA Submission Planned For 2H Of 2024
Tonix Pharmaceuticals Announces Selection Of Two Contract Manufacturing Organizations For The Launch And Commercial Manufacture Of Tonmya For Management Of Fibromyalgia; NDA Submission Planned For 2H Of 2024
Tonix Pharmicals宣佈選擇兩家合同製造組織負責Tonmya的上市和商業化生產，以管理纖維肌痛；計劃於2024年下半年提交保密協議
Tonix Pharmaceuticals Announces Selection Of Two Contract Manufacturing Organizations For The Launch And Commercial Manufacture Of Tonmya For Management Of Fibromyalgia; NDA Submission Planned For 2H Of 2024
Tonix Pharmicals宣佈選擇兩家合同製造組織負責Tonmya的上市和商業化生產，以管理纖維肌痛；計劃於2024年下半年提交保密協議
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。